Boston Bio

Boston_Bio25 Aug 2015

Finance

₹

0.00 (0.00%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Boston Bio

Boston Bio

Finance

Boston_Bio25 Aug 2015

₹

0.00 (0.00%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
13-Feb-2024	BC	Outcome of Board Meeting held on February 12,2024	12-Feb-2024
13-Feb-2024	BC	Outcome of Board Meeting held on February 12,2024	12-Feb-2024
29-Jan-2024	BC	In pursuant to Regulation 30 of the Securities Board and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation 2015, we would like to inform you that the Board of Direc	29-Jan-2024
29-Jan-2024	BC	In pursuant to Regulation 30 of the Securities Board and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation 2015, we would like to inform you that the Board of Direc	29-Jan-2024
29-Dec-2023	BC	Change in Designation of Mr. Kushal Rathore as Managing Director of the Company.	28-Dec-2023

No Rights has been declared by Boston_Bio

Book Closure

Record Date	Split Date	Purpose
12-Feb-2024	-	Outcome of Board Meeting held on February 12,2024
12-Feb-2024	-	Outcome of Board Meeting held on February 12,2024
29-Jan-2024	-	In pursuant to Regulation 30 of the Securities Board and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation 2015, we would like to inform you that the Board of Direc
29-Jan-2024	-	In pursuant to Regulation 30 of the Securities Board and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation 2015, we would like to inform you that the Board of Direc
28-Dec-2023	-	Change in Designation of Mr. Kushal Rathore as Managing Director of the Company.

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Boston Bio Systems Ltd ₹16.76(0.00/0.00%)	16.76	+0.00	11.73	24.33	0.00	1.78
Tata Investment Corporation Ltd ₹6,506.10(-59.75/-0.91%)	6,506.10	-59.75	32,917.81	201.36	117.63	1.40
Alfred Herbert (India) Ltd ₹1,619.85(-33.05/-2.00%)	1,619.85	-33.05	124.73	134.22	129.17	1.24
Aravali Securities & Finance Ltd ₹7.44(+0.35/4.94%)	7.44	+0.35	11.27	90.77	0.00	-26.24
Utique Enterprises Ltd ₹9.29(-0.10/-1.06%)	9.29	-0.10	51.72	89.21	77.42	0.73
Bajaj Holdings & Investment Ltd ₹8,237.50(+122.60/1.51%)	8,237.50	+122.60	91,675.14	18.68	31.65	4.87

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Sep 18	Jun 18	Mar 18	Dec 17	Sep 17	Jun 17
Gross Sales	0.20	0.25	0.19	0.24	0.02	0.21
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	0.20	0.25	0.19	0.24	0.02	0.21
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.00	0.00	0.00	0.00	0.00	0.00
Total Income	0.20	0.25	0.19	0.25	0.02	0.21
Total Expenditure	0.19	0.25	0.20	0.24	0.01	0.20
PBIDT	0.00	0.00	-0.01	0.00	0.00	0.00
Interest	0.00	0.00	0.00	0.00	0.00	0.00
PBDT	0.00	0.00	-0.01	0.00	0.00	0.00
Depreciation	0.00	0.00	0.00	0.00	0.00	0.00
Tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Profit After Tax	0.00	0.00	-0.01	0.00	0.00	0.00
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	0.00	0.00	-0.01	0.00	0.00	0.00

EPS (Unit Curr.)	0.00	0.00	0.00	0.04	0.00	0.00
EPS (Adj) (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Calculated EPS (Unit Curr.)	0.00	0.00	-0.01	0.00	0.00	0.01
Calculated EPS (Adj) (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Calculated EPS (Ann.) (Unit Curr.)	0.01	0.00	-0.04	0.01	0.01	0.03
Calculated EPS (Adj) (Ann.) (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	7.00	7.00	7.00	7.00	7.00	7.00
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	0.00	0.00	-5.26	0.00	0.00	0.00
PBDTM(%)	0.00	0.00	-5.26	0.00	0.00	0.00
PATM(%)	0.00	0.00	-5.26	0.00	0.00	0.00

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 18	Mar 17	Mar 16	Mar 15	Mar 14	Mar 13
SOURCES OF FUNDS :
Share Capital	7.00	7.00	7.00	7.00	7.00	7.00
Reserves Total	-0.40	-0.40	-0.40	-0.40	-0.40	-0.40
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	6.60	6.60	6.60	6.60	6.60	6.60
Secured Loans	0.00	0.00	0.00	0.00	0.00	0.00
Unsecured Loans	0.87	0.87	0.87	0.12	0.12	0.12
Total Debt	0.87	0.87	0.87	0.12	0.12	0.12
Total Liabilities	7.47	7.47	7.47	6.72	6.72	6.72
APPLICATION OF FUNDS :
Gross Block	0.00	0.00	0.00	0.00	0.00	0.00
Less : Accumulated Depreciation	0.00	0.00	0.00	0.00	0.00	0.00
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	0.00	0.00	0.00	0.00	0.00	0.00
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.00	0.00	0.00	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	0.02	0.00	0.00	0.00	0.00	0.00
Sundry Debtors	2.51	1.95	1.49	0.00	0.00	0.00
Cash and Bank	0.06	0.01	0.04	0.07	0.01	0.01
Loans and Advances	1.68	1.65	1.65	0.91	0.00	0.00
Total Current Assets	4.28	3.62	3.18	0.97	0.01	0.01
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	2.60	1.90	1.46	0.00	0.00	0.00
Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Total Current Liabilities	2.60	1.90	1.46	0.00	0.00	0.00
Net Current Assets	1.67	1.72	1.72	0.97	0.00	0.01
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liability	0.00	0.00	0.00	0.00	0.00	0.00
Net Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Total Assets	1.67	1.72	1.72	0.97	0.00	0.01
Contingent Liabilities	0.00	0.00	0.00	0.00	0.00	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2018	Mar 2017	Mar 2016	Mar 2015
Cash and Cash Equivalents at Beginning of the year	0.01	0.04	0.07	0.01
Net Cash from Operating Activities	0.13	-0.02	-0.03	0.97
Net Cash Used In Investing Activities	-0.08	0.00	0.00	-0.91
Net Cash Used In Financing Activities	0.00	0.00	0.00	0.00
Net Inc./Dec In Cash And Cash Equivalents	0.05	-0.02	-0.03	0.06
Cash And Cash Equivalents At End Of The Year	0.06	0.01	0.04	0.07

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

2.14%

FII Shareholding

0.00%

DII Shareholding

0.00%

Public Shareholding

97.86%

**Promoter pledged shareholding 2.14%

About Boston Bio Systems Ltd

Boston Bio Systems Ltd is in the Finance sector, having a market capitalization of Rs. 11.73 crores. It has reported a sales of Rs. 0.2 crores and a net profit of Rs. 0 crores for the quarter ended December 2018. The company management includes , Amit Ashwinbhai Pandya,RameshKumar G Dave,Kushal Rathore,Ankit Sanjay Disoja,Savita Disoja,Sanjay Sodani,Pratik Satish Patil (Boston Bio Systems Ltd) among others.

Chairman

Registered office

17/B 4th Floor Mirzapur,Sandesh Commerical Complex,Ahmedabad,Gujarat,380001

FAX :

Background

Incorporation Year1995

Face Value₹10

Market Lot1

How to buy Boston Bio shares on nse?

To buy Boston Bio shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Boston Bio share price today?

The Boston Bio shares price on nse is Rs.16.76 today.

What is the market cap of Boston Bio shares on BSE ?

The company has a market capitalization of Rs.11.73Cr

What is the PE & PB ratio of Boston Bio shares ?

PE is 0 and PB is 1.78

What is the 52 Week High and Low of Boston Bio shares?

Boston Bio stock price high: Rs.16.76 Boston Bio stock price low: Rs.0